Apoptosis induction and inhibition of cellular proliferation by angiotensin II: Possible implication and perspectives

Acta Physiologica Hungarica

Volumn 87, Issue 1, 2000, Pages 5-24

  Antus, B ^a   Mucsi, I ^a   Rosivall, László ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Angiotensin II; Apoptosis; AT1 and AT2 receptors; Glomerulosclerosis; Heart failure; Proliferation

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; RECEPTOR SUBTYPE;

ANIMAL CELL; ANIMAL EXPERIMENT; BLOOD PRESSURE; CELL GROWTH; CELL PROLIFERATION; ELECTROLYTE BALANCE; FIBROGENESIS; GLOMERULOSCLEROSIS; HEART FAILURE; MITOSIS INHIBITION; MOLECULAR CLONING; NONHUMAN; PATHOGENESIS; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0033818108     PISSN: 0231424X     EISSN: None     Source Type: Journal    
DOI: 10.1556/aphysiol.87.2000.1.2     Document Type: Review

References (108)

1. Navar, L. G., Rosivall, L.: Contribution of the renal-angiotensin system to the control of intrarenal haemodynamics. Kidney Int. 25, 857-868 (1984).
2. Rosivall, L.: Intrarenal renin-angiotensin systems and its contribution to the regulation of glomerular haemodynamics. Nephrol. Dial. Transplant. 10, 1565-1568 (1995).
3. Wolf, D., Neilson, E. G.: Angiotensin II as a renal growth factor. J. Am. Soc. Nephrol. 3(9), 1531-1540 (1993).
4. Dostal, D. E., Hunt, R. A., Kule, C. E., Bhat, G. J., Karoor, V., McWhinney, C. D., Baker, K. M.: Molecular mechanism of angiotensin II in modulating cardiac function: intracardial effects and signal transaction pathway. J. Moll. Cell. Cardiol. 29, 2893-2902 (1997).
5. Homey, C. J.: Signaling hypertrophy. How many switches, how many wires. Circulation 97, 1890-1892 (1998).
6. Murphy, T. J., Alexander, R. W., Griendling, K. K., Runge, M. S., Bernstein, K. E.: Isolation of cDNA encoding the vascular type-I angiotensin II receptor. Nature 355, 233-236 (1991).
7. Mukoyama, M., Nakajima, M., Horiuchi, M., Sasamura, H., Pratt, R. E., Dzau, V. J.: Molecular cloning of a novel angiotensin II receptor reveals a unique class of seven transmembrane receptor. J. Biol. Chem. 268, 24539-24542 (1993).
8. Sasaki, K., Yamamo, Y., Bardhan, S., Iwai, N., Murray, J. J., Hasegawa, N., Matsuda, Y., Inagami, T.: Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-I receptor gene from bovine adrenocortical cells. Nature 351, 230-232 (1991).
9. Kambayashi, Y., Bardhan, S., Takahasni, K., Tsuzuki, S., Inui, H., Hamakubo, T., Inagami, T.: Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J. Biol. Chem. 25 268, 24543-24546 (1993).
10. Mene, P., Amore, A.: Apoptosis: potential role in renal diseases. Nephrol. Dial. Transplant. 13, 1936-1943 (1998).
11. MacLellan W. B., Schneider M. D.: Death by design. Programmed cell death in cardiovascular biology and disease. Circ. Res. 81, 137-144 (1997).
12. Ozawa, Y., Suzuki, Y., Murakami, K., Miyazaki, H.: The angiotensin II type 2 receptor primarily inhibits cell growth via pertussis toxin-sensitive G proteins. Biochem. Biophys. Res. Commun. 228, 328-333 (1996).
13. Tsuzuki, S., Eguchi, S., Inagami, T.: Inhibition of cell proliferation and activation of protein tyrosine phosphatase mediated by angiotensin II type 2 (AT2) receptor in R3T3 cells. Biochem. Biophys. Res. Commun. 228, 825-830 (1996).
14. 1 receptor: gain-of-function study using gene transfer. Proc. Natl. Acad. Sci. USA. 92, 10663-10667 (1995).
15. Metsärinne, K. P., Stoll, M., Gohlke, P., Paul, M., Unger T.: Angiotensin II is antiproliferative for coronary endothelial cells in vitro. Pharmaceut. Pharmacol. Lett. 2, 150-152 (1992).
16. 2 receptor mediates inhibition of cell proliferation in coronary endothelial cells. J. Clin. Invest. 95, 615-657 (1995).
17. Van Kesteren, C. A., Van Heugten, H. A., Lamers, J. M., Saxena, P. R., Schalekamp, H. A., Danser, A. H.: Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts. J. Moll. Cell. Cardiol. 29, 2147-2157 (1997).
18. Mazzocchi, G., Malendowicz, L. K., Gottardo, G., Rebuffat, P., Nussdorfer, G. G.: Angiotensin II stimulated DNA synthesis in rat adrenal zona glomerulosa cells: receptor subtypes involved and possible signal transaction mechanism. Endocr Res. 23(3), 191-203 (1997).
19. 2 receptor inhibits proliferation and promotes differentiation in PC12W cells. Mol. Cell. Endocrinol. 122, 59-67 (1996).
20. Booz, G. W., Baker, K. M.: Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy. Hypertension 28, 635-640 (1996).
21. Janiak, P., Pillon, A., Prost, J. F., Vilaine, J. P.: Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension 20, 737-745 (1992).
22. 2-subtype receptor prevents the effect of angiotensin II on the rat vascular structure. J. Clin. Invest. 98, 418-425 (1996).
23. 2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin II. Arterioscle. Tromb. Vasc. Biol. 17, 257-264 (1997).
24. 2 angiotensin receptor antagonists in angiotensin II-infused rats. Hypertension 31, 487-492 (1998).
25. 2) receptor mRNA in the rat. Kidney Int. 47, 1095-1100 (1995).
26. 2) receptor protein in rat kidney. Hypertension 30, 1238-1246 (1997).
27. 2 receptors in the developing rat fetus. J. Clin. Invest. 88, 921-933 (1991).
28. Nishimura, H., Yerkes, E., Hohenfellner, K., Miyazaki, Y., Ma, J., Hunley, T. E., Yoshida, H., Ichiki, T., Threadgill, D., Phillips, J. A., Hogan, B. M., Fogo, A., Brock, J. W., Inagami, T., Ichikawa, I.: Role of angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol. Cell. 3, 1-10 (1999).
29. 2) genotype and congenital urinary tract anomalies (CUTA) in two independent cohorts. J. Am. Soc. Nephrol. 8, 397A (abstract) (1997).
30. Goto, M., Mukoyama, M., Suga, S., Matsumoto, T., Nakagawa, M., Ishibashi, R., Kasahara, M., Sugawara, A., Tanaka, I., Nakao, K.: Growth-dependent induction of Angiotensin II type 2 receptor in rat mesangial cells. Hypertension 30, 358-362 (1997).
31. Vermes, I., Haanen, C.: Apoptosis and programmed cell death in health and disease. Adv. Clin. Chem., 31, 177-246 (1999).
32. Cohen J. J.: Apoptosis. Immunol. Today 14, 126-130 (1993).
33. Stewart, B. W.: Mechanisms of apoptosis: Integration of genetic, biochemical, and cellular indicators. J. Natl. Canacer. Inst. 86, 1286-1296 (1994).
34. Yamada, T., Horiuchi, M., Dzau, V. J.: Angiotensin II type 2 receptor mediates programmed cell death. Proc. Natl. Acad. Sci. USA. 93, 156-160 (1996).
35. Horiuchi, M., Hayashida, W., Kambe, T., Yamada, T., Dzau, V. J.: Angiotensin type 2 receptor dephosphorylates bcl-2 by activating mitogen-activated protein kianse phsophatase-1 and induces apoptosis. J. Biol. Chem. 272, 19022-19026 (1997).
36. Bedecs, K., Elbaz, N., Sutren, M., Masson, M., Susin, C., Strosberg, D., Nahmias, C.: Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase. Biochem. J. 325, 449-454 (1997).
37. Yamada, T., Akishita, M., Pollman, M. J., Gibbons, G. H., Dzau, V. J., Horiuchi, M.: Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: an in vitro gene transfer study. Life Sci. 63, 289-295 (1998).
38. Hayashida, W., Horiuchi, M., Grandchamp, J., Dzau, V. J.: Antagonistic actions of Angiotensin II type-1 and type-2 receptors on apoptosis in cultured neonatal rat ventricular myocytes. Hypertension 28, 535 (abstract) (1996).
39. 2 receptor antagonizes Angiotensin II-induced apoptosis in fibroblasts of the mouse embryo. Biochem. Biophys. Res. Commun. 250, 72-76 (1998).
40. Tanaka, M., Ohnishi, J., Ozawa, Y., Sugimoto, M., Usuki, S., Naruse, M., Murakami, K., Miyazaki, H.: Characterization of Angiotensin II receptor type 2 during differentiation and apoptosis of rat ovarian cultured granulosa cells. Biochem. Biophys. Res. Commun. 207, 593-598 (1995).
41. Cigola, E., Kajstura, J., Li, B., Meggs, L. G., Anversa, P.: Angiotensin II activates myocyte cell death in vitro. Exp. Cell. Res., 231, 363-371 (1997).
42. Kajstura, J., Cigola, E., Malhotra, A., Li, P., Cheng, W., Meggs, L. G., Anversa, P.: Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J. Moll. Cell. Cardiol. 29, 859-870 (1997).
43. Li, D., Yang, B., Philips, M. L., Metha, J. L.: Proapoptotic effects of Ang II in human coronary artery endothelial cells: role of AT1 receptor and PKC activation. Am. J. Physiol. 276, H786-H792 (1999).
44. Dimmeler, S., Rippmann, V., Weiland, U., Haendeler, J., Zeiher, A. M.: Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ. Res. 81, 970-976 (1997).
45. Pollmann, M. J., Yamada, T., Horiuchi, M., Gibbson, G. H.: Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and Angiotensin II. Circ. Res. 79, 748-756 (1996).
46. Lane, D. P.: p53, guardian of the genome. Nature 358, 15-16 (1992).
47. Mercer, W. E., Shields, M. T., Amin, M., Sauve, G. J., Appalla, E., Romano, J. W., Ullrich, S. J.: Negative growth regulation in a glioblastoma tumor cell line that conditionally express human wilde-type p53. Proc. Natl. Acad. Sci. USA. 87, 6166-6170 (1990).
48. Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B., Costa, J.: Induction of apoptosis by wide-type p53 in human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA. 89, 4495-4499 (1992).
49. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A., Oren, M.: Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 352, 345-347 (1991).
50. Pierzchalaski, P., Reiss, K., Cheng, W., Cirelli, C., Kajstura, J., Nitahara, J. A., Rizk, M., Capogrossi, M. C., Anversa, P.: p53 induces myocyte apoptosis via the activation of the renin-angiotensin system. Exp. Cell. Res. 234, 57-65 (1997).
51. Leri, A., Claudio, P. P., Li, Q., Wang, X., Reiss, K., Wang, S., Malhotra, A., Kajstura, J., Anversa, P.: Stretch-mediated release of Angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the bcl-2-tobax protein ration in the cell. J. Clin. Invest. 101, 1326-1342 (1998).
52. 2 receptors in regulation of MAPKs and MKP-I by ANG II in adult cardiac myocytes. Am. J. Physiol. 275, H906-H916 (1998).
53. 2 receptors are functionally coupled to protein tyrosine dephosphorylation in NIE-115 neuroblastoma cells. Biochem. J. 306, 87-92 (1995).
54. Hayashida, W., Horiuchi, M., Dzau, V. J.: Intracellular third loop domain of Angiotensin II type-2 receptor. Role in mediating signal transaction and cellular function. J. Biol. Chem. 271, 21985-21992 (1996).
55. βγ subunit, Src family, and Ras in cardiac fibroblasts. Circ. Res. 82, 337-345 (1998).
56. Hamaguchi, A., Kim, S., Yano, M., Yamanaka, S., Iwao, H.: Activation of glomerular mitogen-activated protein kinases in angiotensin II-mediated hypertension. J. Am. Soc. Nephrol. 9, 372-380 (1998).
57. Ishida, M., Ishida, T., Thomas, S. M., Berk, B. C.: Activation of extracellular signal-regulated kinases (ERK1/2) by Angiotensin II is dependent on c-Src in vascular smooth muscle cells. Circ. Res. 82, 7-12 (1998).
58. Huszá;r, T., Mucsi, I., Antus, B., Terebessy, T., Masszi, A., Jeney, C., Hunyady, L., Mihalik, B., Goldberg, H. J., Thekkumkara, T. J., Rosivall, L.: Extracellular signal regulated kinase (ERK) and small GTP-binding protein p21Rac-I are involved in the regulation of gene transcription by angiotensin II. Exp. Nephrol. (in press).
59. Kim, S., Izumi, Y., Yano, M., Hamaguchi, A., Miura, K., Yamanaka, S., Miyazaki, H., Iwao, H.: Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery. Circulation 97, 1731-1737 (1998).
60. Pan, J., Fukada, K., Kodama, H., Makino, S., Takahashi, T., Sano, M., Hori, S., Ogawa, S.: Role of angiotensin II in activation of the JAK/STAT pathway induced by acute pressure overload in the rat heart. Circ. Res. 81, 611-617 (1997).
61. Marrero, M. B., Schieffer, B., Li, B., Sun, J., Harp, J. B., Ling, B. N.: Role of Janus Kinase/Signal Transducer and Activator of Transcription and Mitogen-activated Protein Kinase cascades in Angiotensin II- and Platelet-derived Growth Factor-induced vascular smooth cell proliferation. J. Biol. Chem. 272, 24684-24690 (1997).
62. Force, T., Bonventre, J. V.: Growth factors and mitogen-activated protein kinase. Hypertension 31, 152-161 (1998).
63. Kusuhara, M., Takahashi, E., Peterson, T. E., Abe, J., Ishida, M., Han, J., Ulevitch, R., Berk, B. C.: p38 Kinase is a negative regulator of angiotensin II signal transduction in vascular smooth muscle cells: effects on Na+/H+ exchange and ERK1/2. Circ. Res. 19, 83:824-831 (1998).
64. Kudoh, S., Komuro, I., Mizuno, T., Yamazaki, T., Zou, Y., Shiojima, I., Takekoshi, N., Yazaki, Y.: Angiotensin II stimulates c-Jun NH2-terminal kinase in cultured cardiac myocytes of neonatal rats. Circ. Res. 80, 139-146 (1997).
65. Kawahara, Y., Sunako, M., Tsuda, T., Fukuzaki, H., Fukumoto, Y., Takai, Y.: Angiotensin induces expression of the c-fos gene through protein kinase C activation and calcium ion mobilization in cultured smooth muscle cells. Biochem. Biophys. Res. Commun. 150, 52-59 (1988).
66. Naftilan, A. J., Pratt, R. E., Eldridge, C. S., Dzau, V. J.: Angiotensin induces c-fos expression in smooth muscle cells via transcriptional control. Hypertension 13, 706-711 (1989).
67. Naftilan, A. J., Pratt, R. E., Dzau, V. J.: Induction of platelet-derived growth factor A-chain and c-myc gene expression by angiotensin II in cultured rat vascular smooth muscle cells. J. Clin. Invest. 83, 1419-1424 (1989).
68. 1 receptor. J. Hypertens. 10, 1463-1469 (1992).
69. 2 receptor coupled signal transaction. J. Mol. Med. 76, 202-207 (1998).
70. Hamet, P., Richard, L., Dam, T. V., Teiger, E., Orlov, S. N., Gaboury, L., Gossard, F., Tremblay, J.: Apoptosis in target organs of hypertension. Hypertension 26, 642-648 (1995).
71. Teiger, E., Dam, T. V., Richard, L., Wisnewsky, C., Tea, B. S., Gaboury, L., Tremblay, J., Schwarz, K., Hamet, P.: Apoptosis in pressor overload-induced heart hypertrophy in the rat. J. Clin. Invest. 97, 2891-2897 (1996).
72. Narula, J., Haider, N., Virmani, R., DiSalvo, T. G., Kolodgie, F. D., Hajjar, R. J., Schmidt, U., Semigran, M. J., Dec, W., Khaw, B.: Apoptosis in myocytes in end-stage heart failure. N. Eng. J. Med. 335, 1182-1189 (1996).
73. Goussev, A., Sharov, V. G., Shimoyama, H., Tanimura, M., Lesch, M., Goldstein, S., Sabbah, H. N.: Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure. Am. J. Physiol. 275, H626-H631 (1998).
74. Olivetti, G., Abbi, R., Quaini, F., Kajstura, J., Cheng, W., Nitahara, J. A., Quiani, E., Loreto, C., Beltrami, C., Krajewski, S., Reed, J., Anversa, P.: Apoptosis in the failing human heart. N. Eng. J. Med. 336, 1131-1141 (1997).
75. Hamet, P., deBlois, D., Dam, T. V., Richard, L., Teiger, E., Tea, B. S., Orlov, S. N., Tremblay, J.: Apoptosis and vascular wall remodeling in hypertension. Can. J. Physiol. Pharmacol. 74, 850-861 (1996).
76. Gottlieb, R. A., Burleson, K. O., Kloner, R. A., Babior, B. M., Eiger, R. L.: Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J. Clin. Invest. 94, 1621-1628 (1994).
77. Schunkert, H., Dzau, V. J., Tang, S. S., Hirsch, A. T., Apstein, C. S., Lorell, B. H.: Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: effects on coronary resistance, contractility and relaxation. J. Clin. Invest. 86, 1913-1920 (1990).
78. Baker, K. M., Chermin, M. I., Wixson, S. K., Aceto, J. F.: Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am. J. Physiol. 259, H324-H332 (1990).
79. Sadoshima, J., Xu, Y., Slayter, H. S., Izumo, S.: Autocrine release of angiotensin II mediates stretch induced hypertrophy of cardiac myocytes in vitro. Cell 75, 977-984 (1993).
80. Diez, J., Panizo, A., Hernandez, M., Vega, F., Sola, I., Fortuno, M. A., Pardo, J.: Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats. Hypertension 30, 1029-1034 (1997).
81. 1 blockade with losartan. Hypertension 32, 280-286 (1998).
82. Sharifi, A. M., Schiffrin, E. L.: Apoptosis in vasculature of spontaneously hypertensive rats. Effect of an angiotensin converting enzyme inhibitor and a calcium channel antagonist. Am. J. Hypertens. 11, 1108-1116 (1998).
83. Uhal, B. D., Gidea, C., Bargout, R., Bifero, A., Ibarra-Sunga, O., Papp, M., Flynn, K., Filippatos, G.: Captopril inhibits apoptosis in human lung epithelial cells: a potential antfibrotic mechanism. Am. J. Physiol. 275, L1013-L1017 (1998).
84. Wang, R., Zagariya, A., Ibarra-Sunga, O., Gidea, C., Ang, E., Deshmukh, S., Chaudhary, G., Baraboutis, J., Filippatos, G., Uhal, B. D.: Angiotensin II induces apoptosis in human and rat alveolar epithelial cells. Am. J. Physiol. 276, L885-L889 (1999).
85. Harrison, D. J.: Cell death in diseased glomerulus. Histopathology 12, 679-683 (1988).
86. Baker, A. M., Mooney, A., Hughes, J., Lombardi, D., Johnson, R. J., Savill, J.: Mesangial cell apoptosis: the major mechanism for resolution glomerular hypercellularity in experimental mesangial proliferative nephritis. J. Clin. Invest. 94, 2105-2116 (1994).
87. Sugiyama, H., Kashihara, N., Makino, H., Yamasaki, Y., Ota, Z.: Apoptosis in glomerular sclerosis. Kidney Int. 49, 103-111 (1996).
88. Thomas, G. T., Yang, B., Wagner, B. E., Savill, J., El Nahas, A. M.: Cellular apoptosis and proliferation in experimental renal fibrosis. Nephrol. Dial. Transplant. 13, 2216-2226 (1998).
89. Kitamura, H., Shimizu, A., Masuda, Y., Ishizaki, M., Sugisaki, Y., Yamanaka, N.: Apoptosis in glomerular endothelial cells during the development of glomerulosclerosis in the remnant-kidney model. Exp. Nephrol. 6, 328-336 (1998).
90. Rodriguez-Lopez, A. M., Flores, O., Arevalo, M. A., Lopez-Novoa, J. M.: Glomerular cell proliferation and apoptosis in uninephrectomized spontaneously hypertensive rats. Kidney Int. 54 (Suppl. 68), S36-40 (1998).
91. Thomas, S. E., Anderson, S., Gordon, K. L., Oyama, T. T., Shankland, S. J., Johnson, R. J.: Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia. J. Am. Soc. Nephrol. 9, 231-242 (1998).
92. Hocher, B., Thöne-Reineke, C., Rohmeiss, P., Endothelin-1 transgenic mice develop renal cysts, interstitial fibrosis and glomerulosclerosis but not hypertension. J. Clin. Invest. 99, 1380-1389 (1997).
93. Hocher, B., Rohmeiss, P., Thöne-Reineke, C., Schwarz, A., Burst, V., van der Woude, F., Bauer, C., Theuring, F.: Apoptosis in the kidney of endothelin-1 transgenic mice. J. Cardiovasc. Pharmacol. 31 (Suppl. I), S554-556 (1998).
94. Ito, H., Kasagi, N., Shoromi, K., Osaki, M., Adachi, H.: Apoptosis in human allograft kidneys. Analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling. Transplantation 60, 794-798 (1995).
95. Thomas, S. E., Andoh, T. F., Pichler, R. H., Shankland, S. J., Couser, W. G., Bennett, W. M., Johnson, R. J.: Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int. 53, 897-908 (1998).
96. Laine, J., Etelämäki, P., Holmberg, C., Dunkel, L.: Apoptotic cell death in human chronic renal allograft rejection. Transplantation 63, 101-105 (1997).
97. Troung, L. D., Petrusevska, G., Yang, G., Gurpinar, T., Shapell, S., Lechango, J., Rouse, D., Suki, W. N.: Cell apoptosis and proliferation in experimental chronic obstructive uropathy. Kidney Int. 50, 200-207 (1996).
98. Chen, X., Wang, J., Fu, B., Yu, L.: RGD-containing peptides trigger apoptosis in glomerular mesangial cells of adult human kidneys. Biochem. Biophys. Res. Commun. 234, 594-595 (1997).
99. Ortiz, A., Ziyadeh, F. N., Neilson, E. G.: Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys. J. Investig. Med. 45, 50-56 (1997).
100. Ishii, N., Ogawa, Z., Suzuki, K., Numakami, K., Saruta, T., Itoh, H.: Glucose loading induces DNA fragmentation in rat proximal tubular cells. Metabolism 45, 1348-1353 (1996).
101. Zhang, W., Khanna, P., Chan, L. L., Campbell, G., Ansari, N. H.: Diabetes-induced apoptosis in the rat. Biochem. Mol. Med. 61, 58-62 (1997).
102. WAFI,CIPI is increased in experimental diabetic nephropathy: potential role in glomerular hypertrophy. J. Am. Soc. Nephrol. 8, 986-993 (1998).
103. Shiiki, H., Sasaki, Y., Nishino, T., Kimura, T., Kurioka, H., Fujimoto, S., Dohi, K.: Cell proliferation and apoptosis of the glomerular epithelial cells in rats with puromycin amononucleoside nephrosis. Pathobiology 66, 221-229 (1998).
104. Ma, J., Nishimura, H., Fogo, A., Kon, V., Inagami, T., Ichikawa, I.: Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int. 53, 937-944 (1998).
105. Yoshimura, A., Uda, S., Inui, K., Nemoto, T., Sugenoya, S., Sharif, S., Yakota, N., Watanabe, S., Ideura, T.: Expression of bcl-2 and bax in glomerular disease. Nephrol. Dial. Transplant. 14 (Suppl 1), 55-57 (1999).
106. Ketteler, M., Border, W. A., Noble, N. A.: Cytokines and L-arginine in renal injury and repair. Am. J. Physiol. 267, 197-200 (1994).
107. Ketteler, M., Noble, N. A., Border, W. A.: Transforming growth factor-beta and angiotensin II: missing link from glomerular hyperfiltration to glomerulosclerosis? Ann. Rev. Physiol. 57, 279-295 (1995).
108. Singhal, P. C., Gibbons, N., Franki, N., Reddy, K., Sharma, P., Mattana, J., Wagner, J. D., Bansal, V.: Simulated glomerular hypertension promotes mesangial cell apoptosis and expression of cathepsin-B and SGP-2. J. Investing. Medicine 46, 42-50 (1998).